메뉴 건너뛰기




Volumn 21, Issue 6, 2014, Pages 470-475

Diagnosis and treatment of cytomegalovirus 2013

Author keywords

CMX001; Immunotherapy; Letermovir; Maribavir; Next generation sequencing; Novel diagnostic assays; Vaccination

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BENZIMIDAVIR; BORTEZOMIB; BRINCIDOFOVIR; GANCICLOVIR; LETERMOVIR; RITUXIMAB; VALACICLOVIR;

EID: 84927583526     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000090     Document Type: Review
Times cited : (16)

References (33)
  • 1
    • 84891878992 scopus 로고    scopus 로고
    • The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
    • Marek A, Stern M, Chalandon Y, et al. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplant 2014; 49:55-61.
    • (2014) Bone Marrow Transplant , vol.49 , pp. 55-61
    • Marek, A.1    Stern, M.2    Chalandon, Y.3
  • 2
    • 84895924487 scopus 로고    scopus 로고
    • Looking for biological factors to predict the risk of active cytomegalovirus infection in nonimmunosuppressed critically ill patients
    • Bravo D, Clari MA, Aguilar G, et al. Looking for biological factors to predict the risk of active cytomegalovirus infection in nonimmunosuppressed critically ill patients. J Med Virol 2014; 86:827-833.
    • (2014) J Med Virol , vol.86 , pp. 827-833
    • Bravo, D.1    Clari, M.A.2    Aguilar, G.3
  • 3
    • 84905030074 scopus 로고    scopus 로고
    • Cytomegalovirus pneumonia in hematopoietic stem cell recipients
    • Travi G, Pergam SA. Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 2013; 29:200-212.
    • (2013) J Intensive Care Med , vol.29 , pp. 200-212
    • Travi, G.1    Pergam, S.A.2
  • 4
    • 33646589293 scopus 로고    scopus 로고
    • Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation
    • Loeffler J, Steffens M, Arlt EM, et al. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 2006; 44:1847-1850.
    • (2006) J Clin Microbiol , vol.44 , pp. 1847-1850
    • Loeffler, J.1    Steffens, M.2    Arlt, E.M.3
  • 5
    • 0037082494 scopus 로고    scopus 로고
    • Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after highdose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab
    • Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after highdose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99:1486-1488.
    • (2002) Blood , vol.99 , pp. 1486-1488
    • Goldberg, S.L.1    Pecora, A.L.2    Alter, R.S.3
  • 6
    • 84880842646 scopus 로고    scopus 로고
    • A messenger at the door: Cytomegalovirus retinitis in myeloma patients with progressive disease
    • Teh BW, Khot AS, Harrison SJ, et al. A messenger at the door: cytomegalovirus retinitis in myeloma patients with progressive disease. Transpl Infect Dis 2013; 15:E134-E138.
    • (2013) Transpl Infect Dis , vol.15 , pp. E134-E138
    • Teh, B.W.1    Khot, A.S.2    Harrison, S.J.3
  • 7
    • 84901796507 scopus 로고    scopus 로고
    • Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients
    • Hiwarkar P, Gajdosova E, Qasim W, et al. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Clin Infect Dis 2014; 58:1700-1706.
    • (2014) Clin Infect Dis , vol.58 , pp. 1700-1706
    • Hiwarkar, P.1    Gajdosova, E.2    Qasim, W.3
  • 8
    • 0037438514 scopus 로고    scopus 로고
    • Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity
    • Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101:407-414.
    • (2003) Blood , vol.101 , pp. 407-414
    • Boeckh, M.1    Leisenring, W.2    Riddell, S.R.3
  • 9
    • 84905043824 scopus 로고    scopus 로고
    • Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: A study by the European group for blood and marrow transplantation
    • Ljungman P, Brand R, Hoek J, et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis 2014; 59:473-481.
    • (2014) Clin Infect Dis , vol.59 , pp. 473-481
    • Ljungman, P.1    Brand, R.2    Hoek, J.3
  • 10
    • 84892480241 scopus 로고    scopus 로고
    • Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: A retrospective monocentre study on 547 patients
    • Venton G, Crocchiolo R, Fürst S, et al. Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients. Clin Microbiol Infect 2014; 20:160-166.
    • (2014) Clin Microbiol Infect , vol.20 , pp. 160-166
    • Venton, G.1    Crocchiolo, R.2    Fu Rst, S.3
  • 11
    • 84901985882 scopus 로고    scopus 로고
    • The clinical and financial burden of preemptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventive treatment approaches
    • Jain NA, Lu K, Ito S, et al. The clinical and financial burden of preemptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventive treatment approaches. Cytotherapy 2014; 16:927-933.
    • (2014) Cytotherapy , vol.16 , pp. 927-933
    • Jain, N.A.1    Lu, K.2    Ito, S.3
  • 12
    • 84887151263 scopus 로고    scopus 로고
    • CMV reactivation after allogeneic HCT and relapse risk: Evidence for early protection in acute myeloid leukemia
    • Green ML, Leisenring WM, Xie H, et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 2013; 122:1316-1324.
    • (2013) Blood , vol.122 , pp. 1316-1324
    • Green, M.L.1    Leisenring, W.M.2    Xie, H.3
  • 13
    • 84887145602 scopus 로고    scopus 로고
    • CMV: A warrior against leukemia?
    • Ljungman P. CMV: a warrior against leukemia? Blood 2013; 22:1101-1102.
    • (2013) Blood , vol.22 , pp. 1101-1102
    • Ljungman, P.1
  • 14
    • 84872403604 scopus 로고    scopus 로고
    • CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients
    • Cardeñoso L, Pinsky BA, Lautenschlager I, et al. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients. J Clin Virol 2013; 56:108-112.
    • (2013) J Clin Virol , vol.56 , pp. 108-112
    • Cardeñoso, L.1    Pinsky, B.A.2    Lautenschlager, I.3
  • 15
    • 0037090071 scopus 로고    scopus 로고
    • Definitions of cytomegalovirus infection and disease in transplant recipients
    • Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-1097.
    • (2002) Clin Infect Dis , vol.34 , pp. 1094-1097
    • Ljungman, P.1    Griffiths, P.2    Paya, C.3
  • 16
    • 78549241330 scopus 로고    scopus 로고
    • Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
    • Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116:4360-4367.
    • (2010) Blood , vol.116 , pp. 4360-4367
    • Feuchtinger, T.1    Opherk, K.2    Bethge, W.A.3
  • 17
    • 79952470341 scopus 로고    scopus 로고
    • Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
    • Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 2011; 51:591-599.
    • (2011) Transfusion , vol.51 , pp. 591-599
    • Schmitt, A.1    Tonn, T.2    Busch, D.H.3
  • 18
    • 84887515875 scopus 로고    scopus 로고
    • Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    • Kekre N, Tokessy M, Mallick R, et al. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction? Biol Blood Marrow Transplant 2013; 19:1719-1724.
    • (2013) Biol Blood Marrow Transplant , vol.19 , pp. 1719-1724
    • Kekre, N.1    Tokessy, M.2    Mallick, R.3
  • 19
    • 84878785114 scopus 로고    scopus 로고
    • Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients
    • Bacigalupo A, Boyd A, Slipper J, et al. Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. Expert Rev Anti Infect Ther 2012; 10:1249-1264.
    • (2012) Expert Rev Anti Infect Ther , vol.10 , pp. 1249-1264
    • Bacigalupo, A.1    Boyd, A.2    Slipper, J.3
  • 20
    • 79953035666 scopus 로고    scopus 로고
    • Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase 3, double-blind, placebo-controlled, randomised trial
    • Marty FM, Ljungman P, Papanicolaou GA, et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis 2011; 11:284-292.
    • (2011) Lancet Infect Dis , vol.11 , pp. 284-292
    • Marty, F.M.1    Ljungman, P.2    Papanicolaou, G.A.3
  • 21
    • 0028274678 scopus 로고
    • Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group
    • Prentice HG, Gluckman E, Powles RL, et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994; 343:749-753.
    • (1994) Lancet , vol.343 , pp. 749-753
    • Prentice, H.G.1    Gluckman, E.2    Powles, R.L.3
  • 22
    • 55849143692 scopus 로고    scopus 로고
    • Contemporary management of cytomegalovirus infection in transplant recipients: Guidelines from an IHMF workshop
    • Griffiths P, Whitley R, Snydman DR, et al. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop. Herpes 2008; 15:4-12.
    • (2008) Herpes , vol.15 , pp. 4-12
    • Griffiths, P.1    Whitley, R.2    Snydman, D.R.3
  • 23
    • 84899819902 scopus 로고    scopus 로고
    • Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation
    • Chemaly RF, Ullmann AJ, Stoelben S, et al. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 2014; 370:1781-1789.
    • (2014) N Engl J Med , vol.370 , pp. 1781-1789
    • Chemaly, R.F.1    Ullmann, A.J.2    Stoelben, S.3
  • 24
    • 44049085618 scopus 로고    scopus 로고
    • Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
    • Winston DJ, Young JA, Pullarkat V, et al. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 2008; 111:5403-5410.
    • (2008) Blood , vol.111 , pp. 5403-5410
    • Winston, D.J.1    Young, J.A.2    Pullarkat, V.3
  • 25
    • 84878608183 scopus 로고    scopus 로고
    • Maribavir use in practice for cytomegalovirus infection in French transplantation centers
    • Alain S, Revest M, Veyer D, et al. Maribavir use in practice for cytomegalovirus infection in French transplantation centers. Transplant Proc 2013; 45:1603-1607.
    • (2013) Transplant Proc , vol.45 , pp. 1603-1607
    • Alain, S.1    Revest, M.2    Veyer, D.3
  • 26
    • 84884528238 scopus 로고    scopus 로고
    • CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation
    • Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 2013; 369:1227-1236.
    • (2013) N Engl J Med , vol.369 , pp. 1227-1236
    • Marty, F.M.1    Winston, D.J.2    Rowley, S.D.3
  • 27
    • 84886474257 scopus 로고    scopus 로고
    • Detection of cytomegalovirus drug resistance mutations by next-generation sequencing
    • Sahoo MK, Lefterova MI, Yamamoto F, et al. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. J Clin Microbiol 2013; 51:3700-3710.
    • (2013) J Clin Microbiol , vol.51 , pp. 3700-3710
    • Sahoo, M.K.1    Lefterova, M.I.2    Yamamoto, F.3
  • 28
    • 84905561856 scopus 로고    scopus 로고
    • Cytomegalovirus antiviral resistance: Characterization of results from clinical specimens
    • Kleiboeker S, Nutt J, Schindel B, et al. Cytomegalovirus antiviral resistance: characterization of results from clinical specimens. Transpl Infect Dis 2014; 16:561-567.
    • (2014) Transpl Infect Dis , vol.16 , pp. 561-567
    • Kleiboeker, S.1    Nutt, J.2    Schindel, B.3
  • 29
    • 84904884970 scopus 로고    scopus 로고
    • Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
    • Stemberger C, Graef P, Odendahl M, et al. Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy. Blood 2014; 124:628-637.
    • (2014) Blood , vol.124 , pp. 628-637
    • Stemberger, C.1    Graef, P.2    Odendahl, M.3
  • 30
    • 84878908146 scopus 로고    scopus 로고
    • GdT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
    • Scheper W, van Dorp S, Kersting S, et al. gdT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 2013; 27:1328-1338.
    • (2013) Leukemia , vol.27 , pp. 1328-1338
    • Scheper, W.1    Van Dorp, S.2    Kersting, S.3
  • 31
    • 46349108117 scopus 로고    scopus 로고
    • Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
    • Wloch MK, Smith LR, Boutsaboualoy S, et al. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis 2008; 197:1634-1642.
    • (2008) J Infect Dis , vol.197 , pp. 1634-1642
    • Wloch, M.K.1    Smith, L.R.2    Boutsaboualoy, S.3
  • 32
    • 69849102119 scopus 로고    scopus 로고
    • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective
    • Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-1238.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 1143-1238
    • Tomblyn, M.1    Chiller, T.2    Einsele, H.3
  • 33
    • 84859394806 scopus 로고    scopus 로고
    • Complications, diagnosis, management, and prevention of CMV infections: Current and future
    • Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program 2011; 2011:305-309.
    • (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 305-309
    • Boeckh, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.